CX3CR1 and inflammatory bowel disease: A method of treating inflammatory disease (inflammatory bowel disease) in a subject diagnosed with one or more loss-or-function mutations in the CX3CR1 gene using a therapeutically effective amount of an anti-fungal agent (SQ109, voriconazole, fluconazole, etc.) [57].